BackgroundCheck.run
Search For

Martyn J Clarke, 511002 James Pl, Raleigh, NC 27605

Known as:
Martyn Amy Clarke James Clarke Martyn Martin Clarke Martin J Clartt N Clarke Martin E
Related to:
Darrell W Parker 59

Martyn Clarke Phones & Addresses

1002 James Pl, Raleigh, NC 27605    919-9008101   

809 Graham St, Raleigh, NC 27605   

209 Loft Ln, Raleigh, NC 27609   

Emerald Isle, NC   

8610 Queensmere Pl, Richmond, VA 23294   

1002 James Pl, Raleigh, NC 27605   

Social networks

Martyn J Clarke

Linkedin

Work

Company: Gsk Oct 2019 Position: Mdpi value stream lead

Education

Degree: Bachelors, Bachelor of Pharmacy School / High School: University of Bath Institute For Policy Research (Ipr) 1992 to 1999

Skills

Pharmaceutical Industry • Product Development • Formulation • Leadership • Healthcare • Dermatology • Analysis • R

Industries

Pharmaceuticals
Get Report
Control this profile

Mentions for Martyn J Clarke

Martyn Clarke resumes & CV records

Resumes

Martyn Clarke Photo 25

Mdpi Value Stream Lead

Location:
Durham, NC
Industry:
Pharmaceuticals
Work:
Gsk
Mdpi Value Stream Lead Zebulon Gms Gsk
Technical Director Cardinal Health 2001 - 2005
Team Leader Vectura Group Plc. 1998 - 1999
Scientist
Education:
University of Bath Institute For Policy Research (Ipr) 1992 - 1999
Bachelors, Bachelor of Pharmacy University of Bath Institute For Policy Research (Ipr) 1996 - 1999
Doctorates, Doctor of Philosophy, Philosophy
Skills:
Pharmaceutical Industry, Product Development, Formulation, Leadership, Healthcare, Dermatology, Analysis, R

Publications & IP owners

Us Patents

Novel Method Of Use And Compositions

US Patent:
2021003, Feb 4, 2021
Filed:
May 18, 2020
Appl. No.:
16/876179
Inventors:
- Seoul, KR
Martyn J. CLARKE - Zebulon NC, US
Zheng GUO - Aarhus, DK
Bianca PÉREZ - Aarhus, DK
Anthony V. RAWLINGS - Cheshire, GB
International Classification:
A61K 8/06
A61K 8/34
A61K 8/37
A61K 8/55
A61Q 19/00
A61K 9/107
A61K 9/00
A61K 47/14
A61K 8/02
A61K 8/36
Abstract:
The present invention is directed to a method for improving the occlusiveness of a topical pharmaceutical or cosmetic formulation in use in a patient in need thereof, comprising adding to the formulation at least 0.1- to about 10% w/w of one or more of a monofatty acid ester of glycerin and/or one or more of a monofatty acid ester of glycol, or mixtures thereof.The present invention is also directed to a method for maintaining skin barrier efficiency of the stratum corneum of a patient in need thereof, comprising applying to the skin of said patient a pharmaceutical or cosmetic formulation containing at least 3% w/w of one or more of a monofatty acid ester of glycerin and/or one or more of a monofatty acid ester of glycol, or mixtures thereof.

Novel Occlusive Compositions

US Patent:
2021001, Jan 21, 2021
Filed:
Jun 4, 2020
Appl. No.:
16/892592
Inventors:
- Seoul, KR
Martyn J. Clarke - Zebulon NC, US
Anthony V. Rawlings - Cheshire, GB
International Classification:
A61K 8/06
A61K 8/37
A61Q 19/00
A61K 8/34
A61K 8/55
A61K 8/02
A61Q 17/00
A61K 8/36
Abstract:
The invention provides for a topical o/w emulsion having moisturizing, and protecting, repairing or restoring the skin lipid barrier of the lips of a mammal, and is a topical oil-in-water emulsion composition comprising:

Novel Formulations

US Patent:
2020025, Aug 13, 2020
Filed:
Nov 8, 2016
Appl. No.:
15/774420
Inventors:
- Wilmington DE, US
Martyn J. CLARKE - Zebulon NC, US
International Classification:
A61K 31/327
A61K 9/00
A61K 47/26
A61K 47/32
A61K 47/10
A61K 8/38
A61K 8/60
A61K 8/81
A61K 8/34
A61Q 19/10
A61P 17/10
Abstract:
The present invention is directed to a novel combination of excipients with an active ingredient, such as Benzoyl Peroxide based (BPO) which is subject to degradation. In one embodiment the invention is a topical pharmaceutical or cosmetic cleanser composition comprising benzoyl peroxide present in an amount from about 2.0 to about 20% w/w; water, at least one anionic surfactant which is a alkylpolyglucoside (AG) derivative surfactant; at least one humectant, a thickening agent, and optionally at least one dermatologically acceptable excipient.

Novel Method Of Use And Compositions

US Patent:
2018031, Nov 1, 2018
Filed:
Oct 25, 2016
Appl. No.:
15/770856
Inventors:
- Wilmington DE, US
Martyn J. CLARKE - Zebulon NC, US
Zheng GUO - AArhus, DK
Bianca PÉREZ - Aahus, DK
Nthony V. RAWLINGS - Cheshire, GB
International Classification:
A61K 8/06
A61K 8/37
A61K 8/34
A61K 8/55
A61K 8/36
A61Q 19/00
Abstract:
Aspects of the present invention are directed to a method for improving the occlusiveness of a topical pharmaceutical or cosmetic formulation in use in a patient in need thereof, comprising adding to the formulation at least 0.1- to about 10% w/w of one or more of a monofatty acid ester of glycerin and/or one or more of a monofatty acid ester of glycol, or mixtures thereof.Aspects of the present invention are also directed to a method for maintaining skin barrier efficiency of the stratum corneum of a patient in need thereof, comprising applying to the skin of said patient a pharmaceutical or cosmetic formulation containing at least 3% w/w of one or more of a monofatty acid ester of glycerin and/or one or more of a monofatty acid ester of glycol, or mixtures thereof.

Novel Occlusive Compositions

US Patent:
2018031, Nov 1, 2018
Filed:
Oct 25, 2016
Appl. No.:
15/770873
Inventors:
- Wilmington DE, US
Martyn J. CLARKE - Zebulon NC, US
Anthony V. RAWLINGS - Cheshire, GB
International Classification:
A61K 8/06
A61K 8/34
A61K 8/55
A61K 8/37
A61K 8/36
A61Q 19/00
A61Q 17/00
Abstract:
The invention provides for a topical o/w emulsion having moisturizing, and protecting, repairing or restoring the skin lipid barrier of the lips of a mammal, and is a topical oil-in-water emulsion composition comprising: a discontinuous oil phase; a continuous aqueous phase comprising water; a thickening agent; at least one lamellar membrane structure comprising an alkyl amphiphilic component, an ester of a branched fatty acid and a branched fatty alcohol, a fatty acid, a fatty alcohol, and optionally a phospholipid; and wherein in use the composition has a water vapor transmission rate of less than 65 g·m·hrmeasured in vitro.

Novel Compositions

US Patent:
2018030, Oct 25, 2018
Filed:
Mar 9, 2018
Appl. No.:
15/916360
Inventors:
- Wilmington DE, US
Martyn J. Clarke - Zebulon NC, US
Dara Lisa Dinner - King of Prussia PA, US
Alireza Shalviri - Warren NJ, US
International Classification:
A61K 8/34
A61K 8/06
A61K 8/58
A61K 8/36
A61K 8/37
A61K 8/31
A61Q 19/00
A61K 31/5375
A61K 9/00
A61K 9/107
A61K 47/24
A61K 47/10
A61K 47/12
Abstract:
The invention provides a topical o/w emulsion which moisturizes, and protects, repairs or restores the skin lipid barrier of a mammal. The topical o/w emulsion composition comprises: In one embodiment, the composition, in use, has a water vapor transmission rate of less than or about 75 g·m·hrmeasured in vitro using the modWVTR test methodology.

Novel Occlusive Formulations

US Patent:
2018030, Oct 25, 2018
Filed:
Oct 25, 2016
Appl. No.:
15/770827
Inventors:
- Wilmington DE, US
Martyn J. CLARKE - Zebulon NC, US
Anthony V. RAWLINGS - Cheshire, GB
International Classification:
A61K 8/55
A61Q 19/08
A61Q 19/00
A61K 8/06
A61K 8/34
Abstract:
The invention provides a topical o/w emulsion which moisturizes, and protects, repairs or restores the skin lipid barrier of a mammal. The topical o/w emulsion composition comprises a discontinuous oil phase; a continuous aqueous phase comprising water; a thickening agent; at least one lamellar membrane structure comprising a phospholipid, a fatty alcohol, and a fatty acid; and wherein in use the composition has a water vapor transmission rate of less than about 70 g·m·hrmeasured in vitro using the modWVTR test methodology.

Novel Formulations

US Patent:
2017012, May 11, 2017
Filed:
Nov 8, 2016
Appl. No.:
15/346209
Inventors:
- Wilmington DE, US
Martyn J. CLARKE - Zebulon NC, US
International Classification:
A61K 31/327
A61K 47/32
A61K 47/10
A61K 47/12
A61Q 19/00
A61K 8/81
A61K 8/34
A61K 8/36
A61Q 19/10
A61K 9/00
A61K 8/38
Abstract:
The present invention is directed to a novel combination of excipients with an active ingredient, such as Benzoyl Peroxide based (BPO) which is subject to degradation. In one embodiment the invention is a topical pharmaceutical or cosmetic cleanser composition comprising benzoyl peroxide present in an amount from about 2.0 to about 20% w/w; water, at least one anionic surfactant which is a alkylpolyglucoside (AG) derivative surfactant; at least one humectant, a thickening agent, and optionally at least one dermatologically acceptable excipient.

Isbn (Books And Publications)

E. T. A. Hoffmann'S Musical Writings: Kreisleriana, The Poet And The Composer, Music Criticism

Author:
Martyn Clarke
ISBN #:
0521235200

E. T. A. Hoffmann'S Musical Writings: Kreisleriana, The Poet And The Composer, Music Criticism

Author:
Martyn Clarke
ISBN #:
0521543398

Possible Relatives

Cynthia C Clarke  David B Clarke  Dawn M Clarke  Dayna Clarke  Dean Clarke  Deana F Clarke  Deanna L Clarke  Martyn B Johnson  Martyn R Jones  Martyn E Wilkinson 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.